Plasma exchange for severe attacks of inflammatory demyelinating diseases of the central nervous system

Journal of Clinical Apheresis

Volumn 16, Issue 1, 2001, Pages 39-42

  Weinshenker, Brian G ^a  

^a MAYO CLINIC   (United States)

Author keywords

Inflammatory demyelinating disease; MS; Neuromyelitis optica; Plasma exchange; Transverse myelitis

Indexed keywords

CORTICOSTEROID;

CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROSSOVER PROCEDURE; DEMYELINATING DISEASE; HUMAN; INFLAMMATORY DISEASE; MULTIPLE SCLEROSIS; PLASMAPHERESIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT FAILURE; TREATMENT OUTCOME;

DEMYELINATING AUTOIMMUNE DISEASES, CNS; HUMANS; PLASMA EXCHANGE; RANDOMIZED CONTROLLED TRIALS;

EID: 0035033082     PISSN: 07332459     EISSN: None     Source Type: Journal    
DOI: 10.1002/jca.1010     Document Type: Conference Paper

References (10)

1. Therapeutic plasma exchange for acute inflammatory demyelinating syndromes of the central nervous system
2. Studies on the natural history of multiple sclerosis. 7. Correlates of clinical change in an early bout
3. Plasmapheresis in acute episodes of fulminant CNS inflammatory demyelination
4. Therapeutic plasma exchange
5. Double-blind study of true vs. sham plasma exchange in patients treated with immunosuppression for acute attacks of multiple sclerosis
6. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease
7. One disease or many?
8. Four-year follow-up of a case of acute multiple sclerosis of the Marburg type
9. Long-term follow-up of acute partial transverse myelopathy
10. Multiple sclerosis: In situ evidence for antibody- and complement-mediated demyelination